HLS Therapeutics Inc has had a tough week, with a slight drop in stock price despite no major news from the company.
HLS Therapeutics Inc (HLS.TO) is currently facing a challenging market, experiencing a 1.33% decline over the past week. The stock closed at C$3.70, with no significant news affecting its performance. Let’s take a closer look at the recent price movements and technical indicators for HLS Therapeutics.
Investor takeaway: With the recent price drop and no major news, investors should keep a close watch on HLS Therapeutics for signs of recovery or further declines.
Advertisement
HLS Therapeutics Inc
HLS.TO
HLS.TO
HLS Therapeutics Inc
WealthAwesomeMarket cap
$129.93M
52W high
$5.64
52W low
$3.56
1W change
+7.97%
Beta
0.76
Analyst Price Targets
Based on analyst covering HLS · as of Oct 9, 2026
Wall Street analysts forecast HLS stock price to rise 78.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.49
+78.3% Upside
Previously C$7.52 on Oct 8, 2026
Current Price
C$4.20
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HLS's historical volatility
30-Day Vol
47.9%
Annualized
90-Day Vol
38.4%
Annualized
Trend (90d)
+6.0%
Annualized drift
90d Mean
C$4.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.23 | C$3.59 – C$4.99 |
| 60 trading days | C$4.26 | C$3.37 – C$5.38 |
| 90 trading days | C$4.29 | C$3.22 – C$5.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$3.70
HLS Therapeutics' stock has decreased by 23.71% year-to-date, reflecting ongoing challenges in the healthcare sector.
Bull case
Analysts are optimistic about HLS Therapeutics, with an average target price of C$7.31. This suggests a potential upside of nearly 98%, indicating that there may be significant growth opportunities ahead.
Bear case
The company is currently facing a negative profit margin of -15.2%, which raises concerns about its financial health and sustainability in a competitive market.
Price Action Overview
HLS Therapeutics Inc (HLS.TO) has seen a slight decline this week, closing at C$3.70, unchanged for the day but down 1.33% over the past week. The stock has dropped 8.19% in the last month and 23.71% year-to-date.
Company News and Catalysts
Advertisement
This week, HLS Therapeutics did not announce any major news that would typically affect stock performance. However, previous reports indicate that the company has been active in sharing its financial results for Q1 and Q2 of 2026, highlighting revenue growth and operational cash flow. The latest report showed Q2 2026 revenue of $14.2 million and a cash flow of $4.6 million, which may influence investor sentiment.
Technical Picture
From a technical perspective, HLS Therapeutics is currently trading below its 50-day moving average of C$4.05 and its 200-day moving average of C$4.47, indicating a bearish trend. The stock's 52-week range is C$3.56 to C$5.76, with its current price at about 6% of that range. The beta of 0.83 suggests that the stock is less volatile than the broader market. The recent trading volume of 68,582 shares is below the 20-day average volume of 85,326 shares, reflecting lower investor interest.
Insider Activity
No recent insider activity has been reported for HLS Therapeutics, which may suggest a lack of confidence or strategic movement from company executives.
Conclusion
HLS Therapeutics Inc closed at C$3.70, showing no change today but a decline of 1.33% over the week. Investors should monitor upcoming financial results and market conditions that could impact the stock's performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
